Şahin U - Search Results

1

Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.

Moreira ED Jr, Kitchin N, Xu X, Dychter SS, Lockhart S, Gurtman A, Perez JL, Zerbini C, Dever ME, Jennings TW, Brandon DM, Cannon KD, Koren MJ, Denham DS, Berhe M, Fitz-Patrick D, Hammitt LL, Klein NP, Nell H, Keep G, Wang X, Koury K, Swanson KA, Cooper D, Lu C, Türeci Ö, Lagkadinou E, Tresnan DB, Dormitzer PR, Şahin U, Gruber WC, Jansen KU; C4591031 Clinical Trial Group. Moreira ED Jr, et al. Among authors: sahin u. N Engl J Med. 2022 May 19;386(20):1910-1921. doi: 10.1056/NEJMoa2200674. Epub 2022 Mar 23. N Engl J Med. 2022. PMID: 35320659 Free PMC article. Clinical Trial.

2

Serological analysis of human tumor antigens: molecular definition and implications.

Türeci O, Sahin U, Pfreundschuh M. Türeci O, et al. Among authors: sahin u. Mol Med Today. 1997 Aug;3(8):342-9. doi: 10.1016/s1357-4310(97)01081-2. Mol Med Today. 1997. PMID: 9269687 Review.

3

Identification of tumor-associated autoantigens with SEREX.

Türeci O, Usener D, Schneider S, Sahin U. Türeci O, et al. Among authors: sahin u. Methods Mol Med. 2005;109:137-54. doi: 10.1385/1-59259-862-5:137. Methods Mol Med. 2005. PMID: 15585919

4

The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexes.

Koslowski M, Sahin U, Huber C, Türeci O. Koslowski M, et al. Among authors: sahin u. Hum Mol Genet. 2006 Aug 1;15(15):2392-9. doi: 10.1093/hmg/ddl163. Epub 2006 Jun 29. Hum Mol Genet. 2006. PMID: 16809397

5

Targeting the tumor mutanome for personalized vaccination therapy.

Kreiter S, Castle JC, Türeci O, Sahin U. Kreiter S, et al. Among authors: sahin u. Oncoimmunology. 2012 Aug 1;1(5):768-769. doi: 10.4161/onci.19727. Oncoimmunology. 2012. PMID: 22934277 Free PMC article.

6

Antigen identification using SEREX.

Sahin U, Türeci O. Sahin U, et al. Methods Mol Biol. 2013;1061:59-77. doi: 10.1007/978-1-62703-589-7_3. Methods Mol Biol. 2013. PMID: 23963930

7

mRNA-based therapeutics--developing a new class of drugs.

Sahin U, Karikó K, Türeci Ö. Sahin U, et al. Nat Rev Drug Discov. 2014 Oct;13(10):759-80. doi: 10.1038/nrd4278. Epub 2014 Sep 19. Nat Rev Drug Discov. 2014. PMID: 25233993 Review.

8

Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapies.

Omokoko T, Simon P, Türeci Ö, Sahin U. Omokoko T, et al. Among authors: sahin u. Oncoimmunology. 2015 Mar 19;4(7):e1005523. doi: 10.1080/2162402X.2015.1005523. eCollection 2015 Jul. Oncoimmunology. 2015. PMID: 26140230 Free PMC article.

9

Personalized vaccines for cancer immunotherapy.

Sahin U, Türeci Ö. Sahin U, et al. Science. 2018 Mar 23;359(6382):1355-1360. doi: 10.1126/science.aar7112. Science. 2018. PMID: 29567706 Review.

10

Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines.

Vormehr M, Türeci Ö, Sahin U. Vormehr M, et al. Among authors: sahin u. Annu Rev Med. 2019 Jan 27;70:395-407. doi: 10.1146/annurev-med-042617-101816. Annu Rev Med. 2019. PMID: 30691374 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

488 results

Search Page